Archives

by in
Entry Author Date Location
Opsona, And Pharma Backers, Await Day of Reckoning for Kidney Drug 10/29/14 National
Pharmas, Others Bet $33M More on Aileron’s P53 Peptide Drug 10/29/14 Boston
West Coast Biotech Roundup: Genentech, Sutro, Amgen, Regulus & More 10/23/14 San Francisco
West Coast Biotech Roundup: Illumina, Atara, Invitae, Canaan & More 10/17/14 San Francisco
What Seattle Needs (Part 2): Dealing With Amgen’s Upcoming Departure 10/07/14 Seattle
Blessed By Angels, GliaCure Tests New Alzheimer’s Approach In Humans 09/26/14 Boston
Halozyme Gets Key Validation of Enzyme Tech in HyQvia Approval 09/17/14 San Diego
John Maraganore: From “Prototypical Geek” To Canny Alnylam Chief 09/07/14 Boston
West Coast Biotech Roundup: Mapp Bio, Calico, Alder, VentiRx & More 09/04/14 San Diego
Which Countries Excel in Creating New Drugs? It’s Complicated 09/02/14 Seattle
West Coast Biotech Roundup: ARCH, Ebola, ViaCyte, Calithera & More 08/28/14 San Francisco
Roche To Pay $8.3B For Intermune: Who’s Next In Pulmonary Fibrosis? 08/25/14 San Francisco
NJ’s Medicine Chest Thins Again as GE Health Unit Heads for MA 08/19/14 Boston
To Take On New York, Accelerator Makes Big Changes 08/14/14 New York
To Solve Alzheimer’s Mystery, Better Biological Clues Sorely Needed 07/29/14 National
Accelerator Bags $51M, Makes Long-Awaited Move to NYC 07/29/14 New York
West Coast Biotech Roundup: Genentech, CareDx, and More 07/17/14 San Diego
Oh Canada! Versant’s Strategic Shifts Lead to $300M Fund 07/08/14 San Francisco
West Coast Biotech Roundup: Seragon, Ambrx, Pregenen, and More 07/03/14 San Diego
West Coast Biotech Roundup: Affymax, K2, Roche/Stratos, & More 06/26/14 San Francisco
Tapping UCSF Invention, Roche and Versant Dive Into Myelin Repair 06/23/14 San Francisco
East Coast Biotech Roundup: Bluebird, Moderna, Navitor, & More 06/20/14 Boston
Genia Sold: Roche To Incubate Another Novel DNA Sequencing System 06/11/14 San Francisco
Ophthotech, Novartis Team up on $1B Deal for Eye Drug 05/19/14 New York
Outside San Diego, Illumina Looks to Wisconsin for Key R&D 05/08/14 Wisconsin
San Diego’s Ambrx Files for IPO to Advance Antibody-Drug Conjugates 05/05/14 San Diego
Cerulean Limps into Nasdaq Debut With $7 Per Share IPO 04/10/14 Boston
Spero Emerges With $3M, Backing From Roche, & Plans to Disarm Bugs 04/09/14 Boston
Dairyland Innovation: Xconomy Wisconsin’s Top Stories Since December Launch 04/01/14 Wisconsin
San Diego Life Sciences Roundup: Zogenix, Arena, Sorrento, and More 03/31/14 San Diego
Page 1 of 15 next page »